Carregant...
Triple-negative breast cancer and the potential for targeted therapy
Breast cancer is composed of several well-recognized subtypes including estrogen receptor, progesterone receptor and HER2 triple-negative breast cancer (TNBC). Without available targeted therapy options, standard of care for TNBC remains chemotherapy. It is of interest to note that TNBC tumors gener...
Guardat en:
| Publicat a: | Pharmacogenomics |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Future Medicine Ltd
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5694022/ https://ncbi.nlm.nih.gov/pubmed/29095114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2017-0117 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|